Intended for healthcare professionals

News

Pfizer loses appeal over use of branded painkiller pregabalin

BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5578 (Published 17 October 2016) Cite this as: BMJ 2016;355:i5578
  1. Nigel Hawkes
  1. London

Pfizer has failed in its bid to overturn a High Court ruling on the validity of the patents covering its painkiller pregabalin (marketed as Lyrica).

The appeal court upheld the lower court ruling against the company, in which Mr Justice Richard Arnold said that Pfizer had made “groundless claims” that its patent would be infringed unless doctors prescribed Lyrica by brand name as opposed to a generic alternative.1

Pfizer …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription